ArticleJournal of Korean Neurosurgical Society2021
Sacrococcygeal Teratoma : A Tumor at the Center of Embryogenesis.
Article in Journal of Korean Neurosurgical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.
- Fetal sacrococcygeal immature teratoma: a case report and a literature review.BMC pediatrics · 2025Pooled it
- Giant Fetal Sacrococcygeal Teratoma: Prenatal Detection, Monitoring, and Postnatal Management-A Case Report and Literature Review.Clinical case reports · 2026Article
- Mature cystic sacrococcygeal teratoma in adults: A single-center study.World journal of clinical oncology · 2026Article
- Article
- Heavy metals detected in fetal and placental tissues in a pregnancy complicated by severe fetal growth impairment and sacrococcygeal teratoma: a case report.Frontiers in toxicology · 2026Article
- A Rare Case of Spontaneous Rupture of Giant Sacrococcygeal Teratoma: A Case Report From Muhimbili National Hospital, Tanzania.Clinical case reports · 2026Article
- Article
- A familial case of VACTERL association with co-occurring sacrococcygeal teratoma: a case report.Oxford medical case reports · 2025Article
- Sacrococcygeal teratoma - prognosis based on prenatal ultrasound diagnosis, single-center experience and literature review.BMC pregnancy and childbirth · 2025Review
- Abdominopelvic tumors of infancy: a pictorial essay.Pediatric radiology · 2025Review
- Fœtal sacrococcygeal teratoma type I: A case report.Radiology case reports · 2025Article
- Case Report: Giant sacrococcygeal teratoma in neonates-a report of three cases.Frontiers in pediatrics · 2025Article
- Evaluating Sacrococcygeal Teratoma in an Adult Female: A Case Report.Case reports in surgery · 2025Article
- Yolk-sac carcinoma mimicking sacrococcygeal teratoma in an infant.Radiology case reports · 2025Article
- Clinical insights and management perspectives in sacrococcygeal teratoma: Beyond the scalpel.Clinical case reports · 2024Article
- Perinatal Outcomes of Intrauterine Interventions for Fetal Sacrococcygeal Teratoma Based on Different Surgical Techniques-A Systematic Review.Journal of clinical medicine · 2024Review
- Adult Onset Sacrococcygeal Teratoma.Cureus · 2023Article
- Role of Alpha-Fetoprotein (AFP) in Diagnosing Childhood Cancers and Genetic-Related Chronic Diseases.Cancers · 2023Review
- Article
- A Long-Term Outcome of the Patients with Sacrococcygeal Teratoma: A Bosnian Cohort.Turkish archives of pediatrics · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Sacrococcygeal teratoma (SCT) is an extragonadal germ cell tumor (GCT) that develops in the fetal and neonatal periods. SCT is a type I GCT in which only teratoma and yolk sac tumors arise from extragonadal sites. SCT is the most common type I GCT and is believed to originate through epigenetic reprogramming of early primordial germ cells migrating from the yolk sac to the gonadal ridges. Fetal SCT diagnosed in utero presents many obstetrical problems. For high-risk fetuses, fetal interventions (devascularization and debulking) are under development. Most patients with SCT are operated on after birth. Complete surgical resection is the key for tumor control, and the anatomical location of the tumor determines the surgical approaches. Incomplete resection and malignant histology are risk factors for recurrence. Approximately 10-15% of patients have a tumor recurrence, which is frequently of malignant histology. Long-term surveillance with monitoring of serum alpha fetoprotein and magnetic resonance imaging is required. Survivors of SCT may suffer anorectal, urological, and sexual sequelae later in their life, and comprehensive evaluation and care are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.